StockDuty Jun 23, 2026 02:31 PM ET
CatalystEarnings

$MKC — BUY 📊

MKC
$51.05
+5.58%
MRNA
$67.27
+12.59%
$MKC — BUY 📊 McCormick & Company, Incorporated manufactures, markets, and distributes herbs, spices, seasoning mixes, condiments, and other flavorful products to the food industry. 🎯 Q2 2026 | Rev $2B | EPS $0.66 vs $0.60 🟢 💡 Consensus expected EPS of $0.60, but MKC delivered $0.66, a ~10% beat. The market is pricing in sluggish growth, yet the beat suggests the company is executing better than feared. 📉 Reward/Risk: 2.3:1 🏢 Business Quality: 7/10 - Leading global spices & seasonings franchise with strong brands, pricing power, and defensive cash flows; consistent operational execution despite input cost volatility. 📊 Valuation: cheap - Triangulation: P/E (ttm) ~17.8x vs. 5-year average ~24x (adjusted for data inconsistencies); EV/EBITDA ~14x vs. 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/MKC0623 Also in play: $MRNA $BNTX $NVAX $CVAC $PFE
McCormick & Company, Incorporated manufactures, markets, and distributes herbs, spices, seasoning mixes, condiments, and other flavorful products to the food industry.
Sources
pipeline